Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
47.96
-1.14 (-2.32%)
Feb 13, 2026, 3:04 PM CST

SHE:002653 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,4051,0561,169775.39575.11453.97
Short-Term Investments
-----410
Trading Asset Securities
-150.13160.06--370.32
Cash & Short-Term Investments
1,4051,2061,329775.39575.111,234
Cash Growth
9.17%-9.23%71.37%34.82%-53.41%0.91%
Accounts Receivable
1,3281,077883.9803.79569.97487.61
Other Receivables
29.840.3546.7947.1478.568.54
Receivables
1,3581,117930.69850.93648.47556.16
Inventory
283.43271.61281.29346259.95223.9
Prepaid Expenses
-22.55----
Other Current Assets
61.77112.53100.0281.3264.981.38
Total Current Assets
3,1082,7302,6412,0541,5482,096
Property, Plant & Equipment
863.31917.09996.041,0741,1371,126
Long-Term Investments
122.11146.99232.46422.17381.19398.83
Other Intangible Assets
1,5571,277751.23708.33682.47599.98
Long-Term Deferred Tax Assets
159.05177.23148.24126.0883.5780.6
Long-Term Deferred Charges
920.61,1071,4271,233822.42587.16
Other Long-Term Assets
483.37443.95457.37430.15350.51108.15
Total Assets
7,2146,7986,6536,0485,0054,997
Accounts Payable
159.85195.89208.99242.44301.4419.95
Accrued Expenses
108.65190.48200.09136.68120.6393.13
Short-Term Debt
105.95242.5799.98484.69452.18740
Current Portion of Long-Term Debt
1,099728.41833.59295.4325.78-
Current Portion of Leases
-10.277.416.648-
Current Income Taxes Payable
93.65.4916.0816.11.7147.73
Current Unearned Revenue
19.820.8714.6126.9628.4426.02
Other Current Liabilities
176.56174.23123.23279.64279.98389.4
Total Current Liabilities
1,7631,5681,5041,4891,5181,716
Long-Term Debt
1,109925854.681,320452.41334.9
Long-Term Leases
6.794.1410.854.5210.91-
Long-Term Unearned Revenue
101.6795.06108.4798.52102.5487.14
Long-Term Deferred Tax Liabilities
7.553.774.012.531.111.33
Other Long-Term Liabilities
--0.38--2.23
Total Liabilities
2,9882,5962,4822,9142,0852,142
Common Stock
1,1201,1201,1141,0761,0771,074
Additional Paid-In Capital
999.12953.57853.38100.8297.6278.57
Retained Earnings
2,1642,1802,2101,8071,7331,787
Treasury Stock
-80.94-80.94-9.15-24.44-38.31-24.76
Comprehensive Income & Other
24.9240.5511.8676.41-26.82-13.3
Total Common Equity
4,2274,2134,1803,0362,8422,902
Minority Interest
-2.04-11.09-9.3697.6878.27-47.65
Shareholders' Equity
4,2254,2024,1713,1332,9202,855
Total Liabilities & Equity
7,2146,7986,6536,0485,0054,997
Total Debt
2,3211,9101,8072,1111,2491,075
Net Cash (Debt)
-915.93-704.22-477.74-1,336-674.16159.39
Net Cash Growth
-----11.29%
Net Cash Per Share
-0.81-0.62-0.44-1.25-0.630.15
Filing Date Shares Outstanding
1,2121,1591,0481,0361,0911,137
Total Common Shares Outstanding
1,2121,1591,0481,0361,0911,137
Working Capital
1,3441,1621,137565.0930.32379.5
Book Value Per Share
3.493.633.992.932.612.55
Tangible Book Value
2,6702,9373,4292,3272,1592,302
Tangible Book Value Per Share
2.202.533.272.251.982.03
Buildings
-931.33965.52922.14931.62684.59
Machinery
-789.01748.62709.94677.15602.24
Construction In Progress
-6.735.8797.988.54335.2
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.